Table 2 Clinical outcomes
Outcome variable | MIT group (n= 55) | CIT group (n= 57) | P value |
|---|---|---|---|
Mean blood glucose (mg/dl) | 125.3 ± 17.8 | 199.9 ± 30.2 | < 0.01 |
Daily dose of insulin (unit/day) | 82 (69 to 111) | 37 (26 to 44) | < 0.01 |
ICU days | 14 (9 to 19) | 15 (11 to 26) | 0.26 |
Ventilator days | 20 (11 to 30) | 23 (11 to 43.5) | 0.19 |
Hospital days | 27 (15 to 36) | 32 (18.5 to 51.3) | 0.052 |
Acute renal injury | 3/55 (5.5%) | 7/57 (12.3%) | 0.10 |
Bloodstream infection | 1/55 (1.8%) | 3/57 (5.3%) | 0.33 |
Red-blood-cell blood transfusion | 12/55 (21.8%) | 15/57 (26.3%) | 0.74 |
Gastrointestinal bleeding | 7/55 (12.7%) | 7/57 (12.3%) | 0.83 |
Number of mild hypoglycemia | 10/55 (18.2%) | 6/57 (10.5%) | 0.37 |
Rate of moderate hypoglycemia per 100 treatment days | 2.4 | 1.5 | 0.18 |
Number of severe hypoglycemia | 2/55 (3.6%) | 1/57 (1.8%) | 0.53 |
Rate of severe hypoglycemia per 100 treatment days | 0.3 | 0.2 | 0.44 |
Hospital mortality rate | 18/55 (32.7%) | 28/57 (49.1%) | 0.08 |